Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
Telix has announced its prostate cancer imaging drug Illuccix won't be negatively impacted by proposed changes to the US medicare system.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SFN | Ann: Change of Company Name and Board Changes-SFN.AX | 20/05/16 | 0 | 1.6K | |||
|
|||||||
SFN | Ann: Completion of Acquisition of Swift Networks-SFN.AX | 20/05/16 | 0 | 1.1K | |||
|
|||||||
SFN | Ann: Prospectus Capital Raising Closed-SFN.AX | 18/05/16 | 0 | 2.0K | |||
|
|||||||
SFN | Ann: Swift Networks Wins Best New Hospitality Product Award-SFN.AX | 13/05/16 | 0 | 1.2K | |||
|
|||||||
SFN | Ann: Capital Raising Update-SFN.AX | 02/05/16 | 0 | 2.1K | |||
|
|||||||
SFN | News: SFN Stanfield Funds Management updates on capital raising | 02/05/16 | 0 | 1.0K | |||
|
|||||||
SFN | Ann: Appendix 4C - quarterly-SFN.AX | 02/05/16 | 0 | 625 | |||
|
|||||||
SFN | Ann: ASX Waiver from Listing Rule 14.7-SFN.AX | 28/04/16 | 0 | 632 | |||
|
See All Discussions